TLR4에 LPS와의 경쟁적 결합을 통한 항산화 및 항염증 활성을 갖는 신규 화합물 및 이의 의학적 용도
    1.
    发明申请
    TLR4에 LPS와의 경쟁적 결합을 통한 항산화 및 항염증 활성을 갖는 신규 화합물 및 이의 의학적 용도 审中-公开
    具有与TLR4结合的LPS竞争的抗氧化剂和抗炎活性的新型化合物及其医疗用途

    公开(公告)号:WO2016032127A2

    公开(公告)日:2016-03-03

    申请号:PCT/KR2015/007655

    申请日:2015-07-23

    CPC classification number: A61K31/505 A61K31/513 C07D239/10

    Abstract: 본 발명은 TLR4에 LPS와의 경쟁적 결합을 통하여 대식세포의 활성을 억제하는 항산화, 항염증의 효과를 갖는 신규화합물 및 이의 의학적 용도에 관한 것으로, 본 발명에 따른 화합물들은 항산화 및 항염증 활성을 지니므로 노인성 질병의 예방 또는 염증 치료에 유용하게 사용될 수 있으며, 또한 TLR4-MD2에 LPS와 경쟁적 binding 함으로써 특히, LPS와 경쟁적인 결합을 통하여 패혈증, 대사성 질환 또는 심혈관계 질환을 예방하고 치료하는데 유용한 약학조성물 또는 건강식품으로 사용될 수 있다.

    Abstract translation: 本发明涉及由于与LPS竞争结合TLR4而抑制巨噬细胞活性的抗氧化和抗炎作用的新型化合物及其医疗用途。 根据本发明的化合物具有抗氧化和抗炎活性,因此可用于老年疾病预防或炎症治疗。 此外,该化合物与LPS竞争结合TLR4-MD2,特别是因此被用作可用于预防和治疗败血症,代谢疾病或心血管疾病或作为健康食品的药物组合物,借助于 与LPS结合TLR4-MD2的竞争。

    피부미백, 항산화 및 PPAR 활성을 갖는 신규 화합물 및 이의 의학적 용도
    7.
    发明公开
    피부미백, 항산화 및 PPAR 활성을 갖는 신규 화합물 및 이의 의학적 용도 有权
    具有皮肤白化,抗氧化剂和PPAR活性的新化合物及其医疗用途

    公开(公告)号:KR1020130060496A

    公开(公告)日:2013-06-10

    申请号:KR1020110126582

    申请日:2011-11-30

    Abstract: PURPOSE: A compound is provided to have skin whitening, antioxidant, and PPAR(Peroxisome Proliferator-Activated Receptor) activity, thereby preventing and treating skin aging and cardiovascular diseases. CONSTITUTION: A compound is represented by chemical formula 1. In chemical formula 1, each of R^1-R^4 is the same or different from each other, and is H, OH, C1-C4 alkoxy, halogen, or O-C(CH3)2-COOH; each of X^1 - X^3 is the same or different from each other, and is H, OH, C1-C4 alkoxy, halogen, thiol, phenoxy, phenylamino, or styrylbenzene; A is one of hetrocyclic rings, benzene or imidazolidine-2,4-dione; Y is CH or N; and n is an integer from 1-3.

    Abstract translation: 目的:提供化合物以具有皮肤美白,抗氧化和PPAR(过氧化物酶体增殖物激活受体)活性,从而预防和治疗皮肤老化和心血管疾病。 构成:化合物由化学式1表示。在化学式1中,R 1〜R 4各自相同或不同,为H,OH,C 1 -C 4烷氧基,卤素或OC( CH 3)2 COOH; H,OH,C 1 -C 4烷氧基,卤素,硫醇,苯氧基,苯基氨基或苯乙烯基苯; X 1〜X 3中的每一个彼此相同或不同。 A是环状环,苯或咪唑烷-2,4-二酮; Y是CH或N; n为1-3的整数。

    피부미백, 항산화 및 PPAR 활성을 갖는 신규 화합물 및 이의 의학적 용도
    8.
    发明公开
    피부미백, 항산화 및 PPAR 활성을 갖는 신규 화합물 및 이의 의학적 용도 有权
    具有皮肤白化,抗氧化剂和PPAR活性的新化合物及其医疗用途

    公开(公告)号:KR1020130045887A

    公开(公告)日:2013-05-06

    申请号:KR1020130042281

    申请日:2013-04-17

    Abstract: PURPOSE: A novel compound with skin whitening, antioxidation, and PPAR activation effects, and a medical use thereof are provided to be used for a pharmaceutical composition or a cosmetic product. CONSTITUTION: A compound is denoted by chemical formula 1. A skin whitening composition contains the compound as an active ingredient. An antioxidative composition for preventing or treating oxidative diseases contains the compound of chemical formula 1 as an active ingredient. The oxidative diseases are selected among skin aging, pigmentation, wrinkling, psoriasis, or eczema. The composition prevents or treats diseases which are regulated by PPAR(peroxisome proliferator-activated receptor) activity. The PPAR includes PPAR alpha or PPAR gamma.

    Abstract translation: 目的:提供具有皮肤美白,抗氧化和PPAR活化作用的新型化合物及其医疗用途,用于药物组合物或化妆品。 构成:化合物由化学式1表示。皮肤美白组合物含有作为活性成分的化合物。 用于预防或治疗氧化性疾病的抗氧化组合物含有化学式1的化合物作为活性成分。 氧化性疾病选自皮肤老化,色素沉着,皱纹,牛皮癣或湿疹。 该组合物预防或治疗由PPAR(过氧化物酶体增殖物激活受体)活性调节的疾病。 PPAR包括PPARα或PPARγ。

    피부미백 및 PPAR 활성을 갖는 신규 화합물 및 이의 의학적 용도
    9.
    发明授权
    피부미백 및 PPAR 활성을 갖는 신규 화합물 및 이의 의학적 용도 有权
    具有皮肤白化和PPAR活性的新化合物及其医疗用途

    公开(公告)号:KR101292478B1

    公开(公告)日:2013-07-31

    申请号:KR1020130013616

    申请日:2013-02-06

    Abstract: PURPOSE: A novel compound with whitening effect and peroxisome proliferator-activated receptor (PPAR) activity is provided to ensure skin whitening activity by suppressing tyrosinase, and to be used in a pharmaceutical composition or a cosmetic product for skin whitening, and as a pharmaceutical composition or a health functional food for preventing and treating obesity, metabolic diseases, or cardiovascular diseases. CONSTITUTION: A compound is denoted by chemical formula 1. A skin whitening composition contains the compound of chemical formula 1 as an active ingredient. The compound is selected from the group consisting of 2- (2,4-dihydroxyphenyl)-5,6- (methylenedioxy)-benzothiazole, 2- (3-methoxy-4-hydroxyphenyl)-5,6- (methylenedioxy)-benzothiazole, 4- (6,7-dihydro-5H-indeno[5,6-d]thiazol-2-yl)benzene-1,3-diol, 5- (6,7-dihydro-5H-indeno[5,6-d]thiazol-2-yl)-2-methoxyphenol, and bromo-4- (6,7-dihydro-5H-indeno[5,6-d]thiazol-2-yl)phenol. A pharmaceutical composition for preventing or treating one disease selected among obesity, metabolic diseases, and cardiovascular diseases contains the compound of chemical formula 1 as an active ingredient, and is regulated by PPAR activity. The PPAR is PPAR alpha or PPAR gamma.

    Abstract translation: 目的:提供一种具有增白效果和过氧化物酶体增殖物激活受体(PPAR)活性的新型化合物,以通过抑制酪氨酸酶来确保皮肤美白活性,并用于药物组合物或化妆品中用于皮肤美白,以及作为药物组合物 或用于预防和治疗肥胖症,代谢疾病或心血管疾病的健康功能食品。 构成:化合物由化学式1表示。皮肤美白组合物含有化学式1的化合物作为活性成分。 该化合物选自2-(2,4-二羟基苯基)-5,6-(亚甲二氧基) - 苯并噻唑,2-(3-甲氧基-4-羟基苯基)-5,6-(亚甲二氧基) - 苯并噻唑 ,4-(6,7-二氢-5H-茚并[5,1-d]噻唑-2-基)苯-1,3-二醇,5-(6,7-二氢-5H-茚并[5,6 d]噻唑-2-基)-2-甲氧基苯酚和溴代-4-(6,7-二氢-5H-茚并[5,1-d]噻唑-2-基)苯酚。 用于预防或治疗选自肥胖,代谢疾病和心血管疾病的一种疾病的药物组合物含有化学式1的化合物作为活性成分,并受PPAR活性调节。 PPAR是PPARα或PPARγ。

Patent Agency Ranking